Alvotech Holdings S.A
Develops and manufactures affordable biosimilar medicines for global patient access.
ALVO | LU
Overview
Corporate Details
- ISIN(s):
- LU2458332611
- LEI:
- 222100DCZBOWV5DZ8372
- Country:
- Luxembourg
- Address:
- 9, RUE DE BITBOURG, L-1273 LUXEMBOURG
- Website:
- https://www.alvotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alvotech is a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines. The company's mission is to improve lives by increasing patient access to high-quality, affordable biologic treatments worldwide. Alvotech operates a vertically integrated platform, managing the entire process from cell line development to fill-and-finish manufacturing. This end-to-end approach provides control, scale, and speed in its development and production processes. For global commercialization, the company forms strategic partnerships with third parties to market and distribute its robust pipeline of biosimilars to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-06 15:00 |
Regulatory News Service
Alvotech og Advanz Pharma fá markaðsleyfi í Bretlandi fyrir Gobivaz, hliðstæðu …
|
Icelandic | 7.2 KB | ||
| 2025-11-06 15:00 |
Regulatory News Service
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Bio…
|
English | 16.4 KB | ||
| 2025-11-04 22:01 |
Report Publication Announcement
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekst…
|
Icelandic | 3.7 KB | ||
| 2025-11-04 22:01 |
Report Publication Announcement
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for…
|
English | 5.9 KB | ||
| 2025-11-02 23:10 |
Legal Proceedings Report
Alvotech birtir nýjar upplýsingar um stöðu umsóknar um markaðsleyfi fyrir AVT05…
|
Icelandic | 6.4 KB | ||
| 2025-11-02 23:10 |
Regulatory News Service
Alvotech Provides Update on the Status of U.S. Biologics License Application fo…
|
English | 7.6 KB | ||
| 2025-10-22 11:00 |
Board/Management Information
Skipulagsbreytingar á viðskiptasviði Alvotech
|
Icelandic | 6.6 KB | ||
| 2025-10-22 11:00 |
Board/Management Information
Alvotech Announces Changes in Global Business Development and Commercial Operat…
|
English | 12.6 KB | ||
| 2025-10-06 10:40 |
Regulatory News Service
Lyfjastofnun Evrópu tekur til umsagnar umsókn um markaðsleyfi fyrir fyrirhugaða…
|
Icelandic | 7.0 KB | ||
| 2025-10-06 10:40 |
Regulatory News Service
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (oma…
|
English | 16.8 KB | ||
| 2025-10-01 10:37 |
Interim Report
Alvotech Q2 2025 - Unaudited Condensed Consolidated Interim Financial Statement…
|
English | 328.9 KB | ||
| 2025-09-22 12:15 |
Regulatory News Service
Evrópska lyfjastofnunin mælir með útgáfu markaðsleyfis fyrir AVT03, fyrirhugaða…
|
Icelandic | 6.1 KB | ||
| 2025-09-22 12:15 |
Regulatory News Service
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech…
|
English | 13.5 KB | ||
| 2025-09-22 10:30 |
Regulatory News Service
Lyfjastofnun Evrópu mælir með leyfi til markaðssetningar á Gobivaz, fyrirhugaðr…
|
Icelandic | 7.6 KB | ||
| 2025-09-22 10:30 |
Regulatory News Service
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech's…
|
English | 17.0 KB |
Automate Your Workflow. Get a real-time feed of all Alvotech Holdings S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alvotech Holdings S.A
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alvotech Holdings S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
